PHENYTOIN BINDING IN HEALTHY-VOLUNTEERS

被引：6
|
作者：
BERG, MJ [1 ]
EBERT, BE [1 ]
FINCHAM, RW [1 ]
SCHOTTELIUS, DD [1 ]
机构：
[1] UNIV IOWA,COLL MED,IOWA CITY,IA 52242
来源：
THERAPEUTIC DRUG MONITORING | 1987年 / 9卷 / 04期
关键词：
D O I：
10.1097/00007691-198712000-00004
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：384 / 388
页数：5
相关论文
共 50 条
  • [1] THE EFFECT OF PIPERINE ON PHARMACOKINETICS OF PHENYTOIN IN HEALTHY-VOLUNTEERS
    BANO, G
    AMLA, V
    RAINA, RK
    ZUTSHI, U
    CHOPRA, CL
    PLANTA MEDICA, 1987, 53 (06) : 568 - 569
  • [2] INTERACTION BETWEEN PHENYTOIN AND THEOPHYLLINE IN HEALTHY-VOLUNTEERS
    ADEBAYO, GI
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1988, 15 (11) : 883 - 887
  • [3] PHARMACOKINETIC INTERACTION BETWEEN INTRAVENOUS PHENYTOIN AND AMIODARONE IN HEALTHY-VOLUNTEERS
    NOLAN, PE
    MARCUS, FI
    HOYER, GL
    BLISS, M
    GEAR, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (01) : 43 - 50
  • [4] PHARMACOKINETIC INTERACTION OF SINGLE DOSES OF QUININE AND CARBAMAZEPINE, PHENOBARBITONE AND PHENYTOIN IN HEALTHY-VOLUNTEERS
    AMABEOKU, GJ
    CHIKUNI, O
    AKINO, C
    MUTETWA, S
    EAST AFRICAN MEDICAL JOURNAL, 1993, 70 (02) : 90 - 93
  • [5] PHARMACOKINETICS AND DOSE PROPORTIONALITY OF ACC-9653, A PRODRUG OF PHENYTOIN IN HEALTHY-VOLUNTEERS
    RIVENBURG, W
    GERBER, N
    DONN, K
    MAYS, D
    BLANSKI, L
    TURLAPATY, P
    LADDU, A
    QUON, C
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 708 - 708
  • [6] RESEARCH ON HEALTHY-VOLUNTEERS
    不详
    LANCET, 1986, 2 (8512): : 900 - 901
  • [7] RESEARCH ON HEALTHY-VOLUNTEERS
    不详
    LANCET, 1987, 2 (8560): : 699 - 699
  • [8] TRIALS IN HEALTHY-VOLUNTEERS
    不详
    LANCET, 1989, 1 (8641): : 797 - 798
  • [9] CHRONOPHARMACOKINETICS OF KETOROLAC IN HEALTHY-VOLUNTEERS
    SRINIVASU, P
    RAMBHAU, D
    RAO, BR
    CLINICAL DRUG INVESTIGATION, 1995, 10 (02) : 110 - 116
  • [10] PHARMACOKINETICS OF PINAZEPAM IN HEALTHY-VOLUNTEERS
    PACIFICI, GM
    PLACIDI, GF
    FORNARO, P
    GOMENI, R
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1983, 3 (05) : 331 - 337
12345